ANN ARBOR, MI / May 11, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported consolidated financial results for the three...
Zomedica Exercises Option to Acquire Structured Monitoring Products
ANN ARBOR, Ml / May 8, 2023 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), today announced it has exercised its option to move forward with the acquisition of Structured Monitoring Products, Inc. (SMP), the makers of VetGuardian™ zero-touch...
Zomedica to Host First Quarter Financial Results Call on May 11
ANN ARBOR, MI / May 2, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Thursday, May 11, at...
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
ANN ARBOR, MI / April 18, 2023 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced today that Larry Heaton, Chief Executive Officer, will provide a strategic...
Zomedica Appoints New Chief Financial Officer
ANN ARBOR, MI / March 17, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Peter L. Donato as its...
Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity – Revenue up 361% from 2021 through combination of acquisitions and organic growth
ANN ARBOR, MI / March 15, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported consolidated financial results for the year...
Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15
ANN ARBOR, MI / March 8, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Wednesday, March 15,...
Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022
ANN ARBOR, MI / February 9, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported its preliminary unaudited results for the...
Zomedica to Participate in the Lytham Partners Investor Select Conference
ANN ARBOR, MI / January 24, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company") announced today that the Company will be participating in the Lytham Partners Investor Select Conference taking place virtually on January 31, 2023.Company WebcastThe...
Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
ANN ARBOR, MI / January 18, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced a strategic restructuring of its existing development...